October 22, 2020
AbbVie has persuaded a Pennsylvania federal judge to move an antitrust suit brought by Perrigo that alleges monopoly control over a blockbuster testosterone treatment to New Jersey district court.
September 02, 2020
Perrigo Co. on Wednesday slammed AbbVie Inc.'s bid to send a Pennsylvania antitrust suit over a testosterone treatment to New Jersey, arguing that the Keystone State court already presided over the same claims brought by regulatory authorities.
May 04, 2020
Perrigo on Monday joined a string of litigants alleging that AbbVie engaged in "sham" patent infringement litigation to delay generic competition for its AndroGel testosterone treatment.